TITLE

POINT/COUNTER

PUB. DATE
April 2009
SOURCE
Hem/Onc Today;4/10/2009, Vol. 10 Issue 7, p11
SOURCE TYPE
Newspaper
DOC. TYPE
Opinion
ABSTRACT
The article presents the views of Derek Raghavan, chair and director of the Cleveland Clinic Taussig Cancer Institute and the M. Frank and Margaret Domiter Rudy Institute Chair, and H. Ballentine Carter, professor of urology and oncology at Johns Hopkins Medicine and director in the Division of Adult Urology at Brady Urological Institute, on whether men older than 75 years be screened for prostate cancer.
ACCESSION #
37292851

 

Related Articles

  • Early Detection of Prostate Cancer. Carter, H. Ballentine; Wolf Jr., J. Stuart // AUANews;Aug2013, Vol. 18 Issue 8, p29 

    An interview with Doctor H. Ballentine Carter, chair of the Practice Guidelines Committee of the American Urological Association (AUA) and deals with the 2013 AUA Guideline on the early detection of prostate cancer.

  • Experts Debate Utility of PSA Velocity as a Criterion for Prostate Biopsy. Mitka, Mike // JAMA: Journal of the American Medical Association;4/20/2011, Vol. 305 Issue 15, p1522 

    The article discusses the role of prostate-specific antigen (PSA) velocity or the rate of change of PSA level in determining whether a biopsy is needed to diagnose prostate cancer. It references a study led by Andrew J. Vickers, published in a 2011 issue of the "Journal of the National Cancer...

  • Active surveillance: Viable in select PCa patients. Overmyer, Mac // Urology Times;8/1/2006, Vol. 34 Issue 9, p24 

    The article reports that according to a study from Johns Hopkins Hospital, Baltimore, Maryland, men may have 2 or more years to make decision without compromising working treatment for the prostate cancer. The study was presented by Christopher Warlick, H. Ballentine Carter and colleagues at the...

  • Study Supports PSA Velocity Risk Count. Fillon, Mike // JNCI: Journal of the National Cancer Institute;7/18/2012, Vol. 104 Issue 14, p1042 

    The article discusses a study which revealed that the prostate-specific antigen velocity (PSAV) risk count provides U.S. physicians a better way to diagnose men for prostate cancer than PSA alone. It was noted that professor H. Ballentine Carter was the first to conduct research on PSAV risk...

  • Men with low-risk forms of prostate cancer are more likely to opt for so-called active surveillance over surgery or radiation when they have a multidisciplinary team of doctors working with them, according to a new study.  // MondayMorning;8/6/2012, Vol. 20 Issue 31, p1 

    The article provides information on a study which reports that while making surgery with multidisciplinary team of doctors men with low risk of prostate cancer choose active surveillance. It states that active surveillance is chosen by the patients to avoid side effects and unnecessary...

  • Raghavan, Sweetenham named HEMONC TODAY's Chief Medical Editors.  // Hem/Onc Today;5/25/2014, Vol. 15 Issue 10, p4 

    The article announces the appointment of Derek Raghavan and John Sweetenham as chief medical editors of "HemOnc Today."

  • The Whole Life Prostate Book: Everything That Every Man-at Every Age-Needs to Know about Maintaining Optimal Prostate Health. Miksanek, Tony // Booklist;5/15/2012, Vol. 108 Issue 18, p9 

    Reviews the book "The Whole Life Prostate Book: Everything That Every Man-at Every Age-Needs to Know about Maintaining Optimal Prostate Health" by H. Ballentine Carter

  • Local health officials rally to stem blacks' cancer fears. Mortland, Shannon // Crain's Cleveland Business;8/28/2006, Vol. 27 Issue 35, p3 

    The article reports on the formation of a plan to boost cancer education and treatment in the black community of Cleveland, Ohio. Physician Derek Raghavan, chairman and director of the Cleveland Clinic's Taussig Cancer Center, said that cancers which are prevalent in the black community like...

  • Pressed for space, Taussig center turns to HealthSpace. Mortland, Shannon // Crain's Cleveland Business;8/21/2006, Vol. 27 Issue 34, p19 

    The article reports that certain administrative offices in the Cleveland Clinic Taussig Cancer Center in Ohio will be shifted to a new home at the HealthSpace Cleveland health museum located across the center. Derek Raghavan, Taussig chairman and director, said that the shift will take place to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics